Dr. Roy Wayne Turner, MD Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 500 Grapevine Hwy, Ste 106, Hurst, TX 76054 Phone: 817-514-6271 Fax: 817-514-6278 |
News Archive
Researchers at the University of Illinois Chicago are now enrolling people into a phase 3 clinical trial that will test if a monoclonal antibody treatment - administered as a series of four shots - will help protect uninfected individuals from acquiring or getting sick from COVID-19 after someone in the household tests positive for COVID-19.
Eisai Co.,Ltd. announced its latest research on evaluation about correlation of amyloid beta (Abeta) in plasma and in cerebrospinal fluid (CSF) by high precision measurement with the newly developed automated protein assay system, jointly developed with Sysmex Corporation, using full automated immunoassay system HISCLTM series for creating the simplified diagnosis of Alzheimer's disease with blood was presented at the Alzheimer's Association International Conference held in Los Angeles, California, United States, from July 14 to 18, 2019.
During the holiday vacation, some Democratic lawmakers appeared to waver on health reform, faced with "tepid public support" for their proposal and "mounting electoral angst for the party," Politico reports. "But through it all — and through what is expected to be multiple near-death experiences for the health care bill in coming weeks — White House and congressional leaders plan to beat back the temptation of 'no' with a hardball argument: Democrats already voted 'yes.' And it would be politically disastrous to flip-flop now" (Brown, 1/12).
Bring the drugs, hold the suds. That summarizes a promising new drug-making technique designed to reduce serious allergic reactions and other side effects from anti-cancer medicine, testosterone and other drugs that are administered with a needle.
SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, announces that it has raised gross proceeds of $4,102,660 from the exercise of Options that were issued as part of the sale of Units to accredited investors during 2010. The Options had an expiration date of January 31, 2011.
› Verified 2 days ago